Viewing Study NCT06464458

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:08 AM
Ignite Modification Date: 2026-02-03 @ 2:31 AM
Study NCT ID: NCT06464458
Status: RECRUITING
Last Update Posted: 2025-02-13
First Post: 2024-06-12
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Optimizing the Management of Sickle Cell Patients on Hydroxyurea: The Value of Therapeutic Pharmacological Monitoring
Sponsor: University Hospital, Strasbourg, France
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Sickle Cell Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Sickle cell View
None Hydroxyurea View
None Therapeutic drug monitoring View
None Pharmacokinetics View
None SIKLOS® View
None HYDREA® View